FDA Approved: TELMISARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (AvKARE)

View source ↗

Summary

FDA approved a supplemental application for a generic fixed-dose combination of telmisartan and hydrochlorothiazide (AvKARE) for the treatment of hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Telmisartan and Hydrochlorothiazide (telmisartan and hydrochlorothiazide)

Snippet

SUPPL AP for TELMISARTAN AND HYDROCHLOROTHIAZIDE (TELMISARTAN AND HYDROCHLOROTHIAZIDE)